Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 12:05 AM
Study NCT ID:
NCT05747794
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-17
First Post:
2023-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination with Paclitaxel Chemotherapy
Sponsor:
Immutep S.A.S.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-02
First Submit QC Date:
None
Study First Post Date:
2023-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-12
Last Update Post Date:
2024-12-17
Last Update Post Date Type:
ACTUAL